---
name: hormone-replacement-therapy-assessment
description: Use when asked to administer, score, or explain a Hormone Replacement Therapy Assessment — HRT eligibility and symptom evaluation using the Menopause Rating Scale (MRS) — grounded in FormExamples/form-examples.
---

# Hormone Replacement Therapy Assessment

HRT eligibility and symptom assessment using the MRS (Menopause Rating
Scale), covering vasomotor, bone, cardiovascular, and breast health.

## Scoring

**Instrument:** MRS — a composite score across somatic, psychological,
and urogenital subscales, categorized by subscale and total severity
ratings.

## What it covers

Demographics; menopause status; the MRS symptom scale; vasomotor
symptoms; bone health; cardiovascular risk; breast health; current
medications; contraindications screen; and treatment preferences.

## Common pitfalls

- **Skipping the contraindications screen because symptoms are
  severe** — symptom severity doesn't override an absolute or relative
  contraindication (e.g. certain cancer histories, unexplained vaginal
  bleeding, active VTE); the screen has to be checked regardless of how
  bothersome the symptoms are.
- **Treating MRS as covering all relevant risk** — the scale measures
  symptom burden, not cardiovascular or breast-cancer risk directly;
  those require their own dedicated review even when the MRS score is
  high.
- **Assuming one HRT regimen fits every eligible patient** — treatment
  choice (systemic vs. local, combined vs. oestrogen-only) depends on
  whether the uterus is present, personal risk factors, and preference;
  eligibility alone doesn't determine the specific regimen.

## Learn more

- [FormExamples: hormone-replacement-therapy-assessment](https://github.com/FormExamples/form-examples/tree/main/forms/hormone-replacement-therapy-assessment) for the full implementation, clinical references, and worked examples.
- [[birth-control-assessment]], [[contraception-assessment]] for related hormonal-eligibility assessments.